WIRE — Patients have now been enrolled in the PARTNERS trial in the Democratic Republic of the Congo, the world's first real attempt to scientifically determine whether anything actually works against Bundibugyo virus disease. It is a joint effort between the Institut National de Recherche Biomédicale in Kinshasa, the Institute of Tropical Medicine in Antwerp, and Oxford's Pandemic Sciences Institute, sponsored by the World Health Organization and run hand in hand with the DRC's Ministry of Public Health. Two treatments are being tested: the antibody MBP134 and the antiviral remdesivir, given alone and in combination, to see whether either can influence the odds of survival.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.